Resources

A systematic review and meta-analysis of randomized controlled trials examines how some inflammatory markers may be affected by physical activity.

Twenty insulin sensitivity indices compared to determine the superior predictor of type 2 diabetes development in Japanese Americans.  

 Study finds that each 1% elevation in HbA1c increased risk for cellulitis in diabetes patients. 

GLP1 RA and SGLT-2 were compared to evaluate coronary health disease reduction in patients with type 2 diabetes.

A new study shows that teenage boys who stutter may have a higher likelihood of developing early-onset type 2 diabetes.

Personalized medicine may provide a better way of determining the ideal range for sodium consumption.

By Sheri Colberg, PhD
Have you heard of TTP399? Despite its completely forgettable name used in clinical trials, this potential new oral medication may have the power to lower and stabilize blood glucose in people with type 1 diabetes (T1D). If approved, TTP399 (which would be given a spiffy new brand name) will be the first oral pill to treat T1D.

Researchers sought to identify the prevalence of metabolic syndrome in patients with type 1 diabetes and its relationship to diabetic complication development. 

High glucose levels are known to potentiate microvascular complications, especially in people with diabetes, but does the same apply to people with normoglycemic levels? 

A woman in her 60s, extremely insulin-sensitive with type 1 diabetes, came for a review of carb counting and blood sugar logs.  Pt had been running blood sugars above the target range. When asking pt why she thought her blood sugars were running high, she stated she was fearful of having low blood sugars....